An independent review announced by the Health Secretary, Wes Streeting, will look at whether there is an overdiagnosis of ...

Lumos Labs has gained US Food and Drug Administration (FDA) clearance for LumosityRx, a prescription digital therapeutic (PDT) that aims to improve attention span in adult patients with attention ...

LumosityRx is a prescription therapeutic app that includes 13 cognitive training games targeting key brain processes connected to attention function.

Researchers discovered that children who went back to school during COVID experienced far fewer mental health diagnoses than ...

Children who returned to in-person school during the COVID-19 pandemic were far less likely to receive mental health ...

A new study finds that school reopenings during the pandemic were associated with declines in diagnoses of anxiety, ...

Supplements, pseudoscience, and inert treatments abound on social media. Here's why some parents come to believe fake fixes ...

Mental health crises are surprisingly common among high performing Gulf business leaders. Many are travelling abroad for ...

"With LumosityRx, we're taking the core science and technology behind Lumosity and applying it to help people with ADHD, where attention is crucial to everyday life," said Dr. Bob Schafer, ...

By Dennis Thompson HealthDay ReporterTUESDAY, Dec. 9, 2025 (HealthDay News) — School closures are linked to significant ...

A petition has been lodged in the Court of Session amid concerns relating to treatment and assessment procedures.